Clinical Trial

A Study of the TheraBionic P1 Device in Breast Cancer

Name: A Study of the TheraBionic P1 Device in Breast Cancer — clinical trial record (NCT07218432)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn if adding cancer-specific amplitude-modulated radiofrequency electromagnetic field therapy (TheraBionic P1 device) to the treatment of resectable early-stage breast cancer will affect the pathological response.

Protocol Amendment History 1 change

notable Trial sites expanded: 1 -> 8 locations 2026-04-22

Trial Details

NCT Number	NCT07218432
Lead Sponsor	Barbara Ann Karmanos Cancer Institute
Conditions	Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage IIIA, Hormone Receptor Positive Tumor, HER2-negative Breast Cancer
Enrollment	24 participants
Start Date	2026-10
Primary Completion	2027-04-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-21